As we continue to adapt to life during a pandemic, we are reminded that the work we do has a direct result in providing innovative treatments to the patients who need them the most. Thank you for partnering with us on this mission.

Virtual ISPOR-US 2021 is taking place this week, and Precision is well-represented. We want to make sure you are aware of the numerous posters and presentations that will be presented by our talented teams from May 17 through May 20. Combined with our colleagues across Precision Value & Health, we will be presenting over 20 workshops, panels, and posters! Please click here for complete details of all that we will be showcasing.

After ISPOR-US, our team will be featured in a number of other forums described more fully below:

Lastly, in follow-up to the NCCN 2021 Virtual Annual Conference, we want to congratulate Meaghan Roach, Caroline Huber, Suepattra May-Slater, and Isha Desai on the successful presentation of their poster “A Qualitative Study Describing Oncology Practitioners’ Approaches to First-Line (1L) Treatment of Metastatic Urothelial Cancer (mUC) in the United States.” Don’t hesitate to reach out to us if you’d like to learn more.

We are always pleased to offer a number of fresh thought leadership pieces and scientific publications from our prolific experts within PRECISIONheor. Just five months into 2021, our teams have already published and disseminated over 20 scientific articles, commentaries, and abstracts! Read on as we highlight a few of the recent studies carried out with help from our teams, as well as discuss some important trends gaining momentum in the healthcare landscape.

Please don’t hesitate to reach out if you’d like to talk to any of our team members about your evidence needs and priorities, and good luck as we dive into the second half of 2021!


Ross Maclean, MD
EVP and Head of Medical Affairs

Kathy Lang, PhD
Senior Vice President

Want updates? Follow PRECISIONheor on LinkedIn!